Conference Coverage

HFSA 2024

See All Content See past conferences

Atlanta, Georgia

September 29, 2024

September 30, 2024

News Conference News HFSA 2024

Biomarker and Echo Data Bolster Vutrisiran’s Promise in ATTR-CM

Two new analyses from HELIOS-B answer important questions, but some uncertainties remain, says Julie Rosenthal.

Additional Coverage

News Conference News HFSA 2024

‘Global Efficacy’ of Aficamten for Obstructive Disease Shown in SEQUOIA-HCM

L.A. McKeown

October 02, 2024

News Conference News HFSA 2024

EXPANDed: Atrial Secondary MR Patients Get Clinical Benefit From TEER

Caitlin E. Cox

October 03, 2024

News Conference News HFSA 2024

FINEARTS-HF: New Analyses Ask, Who Benefits Most From Finerenone?

Michael O'Riordan

October 02, 2024

All Conference Content

Country

First Name

Last Name

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Advertisement

HFSA 2024

Biomarker and Echo Data Bolster Vutrisiran’s Promise in ATTR-CM

Additional Coverage

‘Global Efficacy’ of Aficamten for Obstructive Disease Shown in SEQUOIA-HCM

EXPANDed: Atrial Secondary MR Patients Get Clinical Benefit From TEER

FINEARTS-HF: New Analyses Ask, Who Benefits Most From Finerenone?

@TCTMD

Advertisement

All Conference Content

Advertisement

HFSA 2024

Additional Coverage

Sign Up for Our Newsletter

Advertisement

All Conference Content

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content

HFSA 2024